Home Ingredients R-Lipoic Acid (Natural / Stabilized R-ALA)
Metabolic HealthAntioxidantLongevity

R-Lipoic Acid (Natural / Stabilized R-ALA)

Evidence Level
Strong
2 Clinical Trials
5 Documented Benefits
4/5 Evidence Score

R-Lipoic Acid (R-ALA) is the BIOLOGICALLY ACTIVE ENANTIOMER of alpha-lipoic acid — the naturally occurring form in mitochondria. Distinct from racemic ALA (50/50 R/S mixture) which is the standard cheap supplement. R-ALA is roughly TWICE as potent as racemic ALA per mg. Stabilized R-ALA forms (Na-RALA, BioEnhanced® R-Lipoic Acid) overcome stability issues. Used for diabetic neuropathy, antioxidant support, and metabolic health.

Studied Dose 100-300 mg/day R-ALA (equivalent to ~200-600 mg racemic ALA); diabetic neuropathy 600 mg/day racemic or ~300 mg R-ALA; up to 1,200 mg/day racemic studied in trials
Active Compound (R)-(+)-alpha-lipoic acid (R-ALA / R-LA)

Benefits

Diabetic Peripheral Neuropathy

ALPHA-LIPOIC ACID has the strongest evidence base for any natural compound for diabetic peripheral neuropathy. SYDNEY 2 trial (Ziegler 2006), ALADIN III, and others established efficacy. R-ALA is the active enantiomer; racemic ALA contains 50% S-form which has minimal activity. Most clinical trials used racemic but R-ALA is the active component.

Supported by Trial 1

Antioxidant Activity (Both Water and Lipid Soluble)

ALA is unique among antioxidants in being BOTH water-soluble AND lipid-soluble — accesses both cellular environments. Recycles other antioxidants (vitamin C, vitamin E, glutathione, CoQ10). 'Universal antioxidant' positioning.

Supported by Trial 2

Insulin Sensitivity / Blood Sugar

Improves insulin sensitivity in T2DM and metabolic syndrome. Ansar 2011 and others showed modest glycemic effects. Effect modest; not substitute for evidence-based diabetes medications.

Supported by Trial 2

Mitochondrial Function

Endogenous mitochondrial cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes. Supports cellular energy production.

Heavy Metal Chelation

ALA chelates heavy metals (mercury, arsenic, cadmium) — used in chelation protocols by some practitioners. Modest evidence; not first-line for clinical heavy metal toxicity.

Supported by Trial 2

Mechanism of action

1

Endogenous Mitochondrial Cofactor

R-ALA is the naturally-occurring enantiomer in mitochondria — bound to specific lysine residues on enzymes (lipoyllysine). Cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain ketoacid dehydrogenase, glycine cleavage system.

2

R-ALA vs S-ALA Activity

R-form is biologically active; S-form has minimal direct biological activity. Racemic ALA (50/50 mix) effectively delivers half the active dose at same mg quantity. PURE R-ALA is therefore approximately twice as potent per mg.

3

Glutathione Recycling

ALA reduces oxidized glutathione (GSSG) back to active GSH — supporting endogenous antioxidant capacity beyond just direct ALA antioxidant effects.

4

AMPK Activation

Activates AMP-activated protein kinase (AMPK) — improving glucose uptake, insulin sensitivity, fat oxidation. Same target as metformin and exercise.

Clinical trials

1
Alpha-Lipoic Acid for Diabetic Peripheral Neuropathy — SYDNEY 2 (Ziegler 2006)
PubMed

Multicenter RCT of ALA (600, 1,200, or 1,800 mg/day racemic) vs placebo in 181 diabetic peripheral neuropathy patients for 5 weeks.

181 diabetic neuropathy patients.

All ALA doses significantly improved Total Symptom Score (TSS) vs placebo. 600 mg/day optimal dose-response. Established ALA as evidence-based treatment for diabetic neuropathy. Ziegler 2011 meta-analysis confirmed.

2
ALA for Glycemic Control — Multiple Trials
PubMed

Multiple trials of ALA for glycemic control in T2DM and metabolic syndrome.

T2DM and metabolic syndrome patients.

Modest improvements in fasting glucose, HbA1c, insulin sensitivity. Effect smaller than metformin or other established diabetes therapies. Reasonable adjunct.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GI distress (nausea, abdominal pain, heartburn).
HYPOGLYCEMIA — particularly with insulin/sulfonylureas.
Headache.
Skin rash rare.
INSULIN AUTOIMMUNE SYNDROME (Hirata's disease) — rare reports of severe hypoglycemia from ALA-induced anti-insulin antibodies; HLA-DRB1*04:06 genetic predisposition (more common in Japanese populations); reversible with ALA discontinuation.
Body odor (sulfur compound).

Important Drug interactions

INSULIN / SULFONYLUREAS — additive hypoglycemic effect; monitor blood glucose closely.
Metformin — generally compatible; modest additive.
Thyroid medications — theoretical reduced absorption; separate by 4 hours.
Chemotherapy — theoretical interactions; consult oncologist.
Mitochondrial toxic drugs — ALA may modestly reduce toxicity (theoretical).
Pre-surgery — discontinue 1-2 weeks before to avoid hypoglycemia during fasting.

More Metabolic Health Ingredients

Cardiovascular
Niacin
Niacin, or vitamin B3, is a vital nutrient that supports energy production by serving as a…
Muscle & Recovery
Magnesium
Magnesium is the fourth most abundant mineral in the body and a cofactor for over 300 enzy…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Metabolic Health
Psyllium Husk (Plantago ovata)
Psyllium husk is the soluble fiber derived from the seed husks of Plantago ovata — the mos…

Explore Other Ingredients

Cognitive
PQQ (Pyrroloquinoline Quinone)
Pyrroloquinoline quinone (PQQ) is a redox-active coenzyme and potent antioxidant naturally…
Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…
Athletic Performance
Cordyceps
Cordyceps is a medicinal fungus traditionally used in Tibetan and Chinese medicine for ene…

Frequently asked questions about R-Lipoic Acid (Natural / Stabilized R-ALA)

What is the recommended dosage of R-Lipoic Acid (Natural / Stabilized R-ALA)?

The clinically studied dose for R-Lipoic Acid (Natural / Stabilized R-ALA) is 100-300 mg/day R-ALA (equivalent to ~200-600 mg racemic ALA); diabetic neuropathy 600 mg/day racemic or ~300 mg R-ALA; up to 1,200 mg/day racemic studied in trials. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is R-Lipoic Acid (Natural / Stabilized R-ALA) used for?

R-Lipoic Acid (Natural / Stabilized R-ALA) is studied for diabetic peripheral neuropathy, antioxidant activity (both water and lipid soluble), insulin sensitivity / blood sugar. ALPHA-LIPOIC ACID has the strongest evidence base for any natural compound for diabetic peripheral neuropathy. SYDNEY 2 trial (Ziegler 2006), ALADIN III, and others established efficacy.

Are there side effects from taking R-Lipoic Acid (Natural / Stabilized R-ALA)?

Reported potential side effects may include: Generally well-tolerated. GI distress (nausea, abdominal pain, heartburn). Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does R-Lipoic Acid (Natural / Stabilized R-ALA) interact with medications?

Known drug interactions may include: INSULIN / SULFONYLUREAS — additive hypoglycemic effect; monitor blood glucose closely. Metformin — generally compatible; modest additive. Consult a pharmacist or healthcare provider if you take prescription medications.

Is R-Lipoic Acid (Natural / Stabilized R-ALA) good for metabolic health?

Yes, R-Lipoic Acid (Natural / Stabilized R-ALA) is researched for Metabolic Health support. Improves insulin sensitivity in T2DM and metabolic syndrome. Ansar 2011 and others showed modest glycemic effects. Effect modest; not substitute for evidence-based diabetes medications.